Court Report

Cough-Syrup Abuse by Kids May Draw FDA Restrictions

Pfizer Inc.'s Robitussin and Johnson & Johnson Tylenol Cough may be reviewed for possible U.S. dispensing restrictions because of increasing signs of abuse and injuries among adolescents. Non-medical use of dextromethorphan, a common cough suppressant approved since 1958, accounted for an estimated 7,988 emergency room visits in 2008, up from 4,634 in 2004, according to a U.S. government report yesterday. A Food and Drug Administration advisory panel will meet Sept. 14 to discuss whether the medicine should be a controlled substance. Read more...


Posted by Webmaster at September 2, 2010 01:12 AM